Annexon Quarterly Balance Sheet
NASDAQ: ANNXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Annexon financial position
As of Jun 30, 2026, Annexon reported total assets of $246.1 million, down 7.0% from a year earlier against total liabilities of $60.0 million. Shareholders' equity stood at $186.1 million, or 75.6% of assets. The company held $199.3 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 5.53, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Annexon balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 199.27M | 175.21M | 162.05M | 139.42M | 132.29M | 97.12M | 49.50M | 79.54M | 157.30M | 151.94M | 225.11M | 133.16M |
| Short-Term Investments | 9.97M | 49.82M | 76.29M | 49.30M | 94.73M | 166.57M | 262.52M | 260.58M | 211.40M | 113.01M | 34.61M | 32.11M |
| Total Current Assets | 212.76M | 228.27M | 242.19M | 192.82M | 230.62M | 268.16M | 316.46M | 344.29M | 373.97M | 270.74M | 263.86M | 169.17M |
| Property, Plant & Equipment | 9.68M | 10.11M | 10.62M | 11.15M | 11.65M | 12.19M | 12.64M | 13.17M | 13.70M | 14.23M | 14.77M | 15.31M |
| Total Assets | 246.07M | 262.89M | 277.57M | 229.14M | 264.57M | 303.03M | 350.07M | 378.78M | 406.08M | 304.07M | 297.67M | 203.82M |
| Accounts Payable | 15.73M | 17.53M | 14.93M | 18.22M | 11.52M | 10.44M | 10.43M | 6.75M | 4.13M | 3.97M | 5.49M | 4.81M |
| Total Current Liabilities | 38.48M | 35.94M | 42.63M | 43.58M | 40.64M | 33.55M | 30.51M | 20.05M | 17.15M | 13.13M | 17.93M | 17.17M |
| Total Liabilities | 60.01M | 58.35M | 65.92M | 67.70M | 65.56M | 59.24M | 56.97M | 47.22M | 45.01M | 41.66M | 47.12M | 46.98M |
| Shareholders' Equity | 186.06M | 204.53M | 211.65M | 161.44M | 199.02M | 243.79M | 293.11M | 331.56M | 361.08M | 262.40M | 250.56M | 156.84M |
| Retained Earnings | -1.02B | -961.53M | -917.39M | -869.13M | -814.21M | -765.05M | -710.70M | -662.11M | -627.28M | -597.67M | -572.50M | -544.61M |
| Net Cash (Debt) | 209.24M | 225.03M | 238.34M | 188.72M | 227.02M | 263.70M | 312.02M | 340.12M | 368.70M | 264.95M | 259.72M | 165.27M |
| Shares Outstanding | — | — | 149.36M | — | — | — | 109.38M | — | — | — | 78.37M | — |
This table shows 12 quarterly periods of Annexon's balance sheet, from Q2 2026 back to Q3 2023, across 12 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow ANNX's reporting calendar. What is a balance sheet?